Ming Hou, Dr.
Shandong University
7
7
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ming Hou, Dr
Shandong University
Shared therapeutic areas:
Worked with same sponsors:
Thomas Ortel, MD
Duke University
Shared therapeutic areas:
James Bussel, MD
Weill Medical College, Cornell University
Shared therapeutic areas:
Nigel Key, MD
University of North Carolina, Chapel Hill
Shared therapeutic areas:
Xiaohui Zhang, md
Peking University People's Hospital, Peking University Insititute of Hematology
Shared therapeutic areas:
Mohsen S Elalfy, professor
Ain Shams University
Shared therapeutic areas:
James George, MD
The University of Oklahoma
Shared therapeutic areas:
heng Mei
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Shared therapeutic areas:
Worked with same sponsors:
Jodi Segal, MD
Johns Hopkins University
Shared therapeutic areas:
Joseph Kiss, MD
University of Pittsburgh
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP
Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）
An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)
A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）
All 7 trials loaded